Frazier Healthcare Partners makes Growth Buyout investments in profitable US middle-market healthcare businesses. Frazier Life Sciences invests in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals.
We're tracking Frazier Healthcare Partners's market expansion
How Frazier Healthcare Partners's international expansion compares to its competitors
Frazier Healthcare PartnersYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Frazier Healthcare PartnersYou | 0 | 0 | — | 0 | 0 |
Vice President Sales Operations
View postingUnited States · last wk.
Executive Assistant Office Manager
View postingNew York City Metropolitan Area · last yr.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Frazier Healthcare Partners sold Elevate Patient Financial Solutions to Audax Private Equity and Parthenon Capital. Elevate is a leading provider of technology-enabled specialty revenue cycle management services for hospitals and health systems.
Haisco Pharmaceutical licenses global rights for HSK39004, a dual PDE3/4 inhibitor for COPD, to AirNexis for up to $1.063 billion, marking a breakthrough in Chinese respiratory innovation.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Frazier Healthcare Partners's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
